Reduced efficacy and risk of seizure aggravation when cannabidiol is used without clobazam

Research output: Contribution to journalEditorial

Original languageEnglish (US)
Article number106506
JournalEpilepsy and Behavior
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Cannabidiol
Seizures
clobazam

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Behavioral Neuroscience

Cite this

@article{e9305d98a9d64a1f8c711b8a513f9ddf,
title = "Reduced efficacy and risk of seizure aggravation when cannabidiol is used without clobazam",
author = "Rogawski, {Michael A}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.yebeh.2019.106506",
language = "English (US)",
journal = "Epilepsy and Behavior",
issn = "1525-5050",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Reduced efficacy and risk of seizure aggravation when cannabidiol is used without clobazam

AU - Rogawski, Michael A

PY - 2019/1/1

Y1 - 2019/1/1

UR - http://www.scopus.com/inward/record.url?scp=85072087838&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072087838&partnerID=8YFLogxK

U2 - 10.1016/j.yebeh.2019.106506

DO - 10.1016/j.yebeh.2019.106506

M3 - Editorial

AN - SCOPUS:85072087838

JO - Epilepsy and Behavior

JF - Epilepsy and Behavior

SN - 1525-5050

M1 - 106506

ER -